The effect of chronic co-treatment with risperidone and novel antidepressant drugs on the dopamine and serotonin levels in the rats frontal cortex

Pharmacological Reports : PR
Katarzyna KamińskaK Gołembiowska

Abstract

Preclinical and clinical studies have suggested a beneficial effect of combination treatment with atypical antipsychotic drugs and antidepressants (ADs) in schizophrenia and in drug-resistant depression. In the present study, we investigated the effect of chronic administration of risperidone and ADs (escitalopram or mirtazapine), given separately or jointly on the extracellular levels of dopamine (DA) and serotonin (5-HT) in the rat frontal cortex. The animals were administered risperidone (0.2mg/kg) and escitalopram (5mg/kg) or mirtazapine (10mg/kg) repeatedly for 14days. The release of monoamines in the rat frontal cortex was evaluated using a microdialysis, and DA and 5-HT levels were assayed by HPLC. We also measured the locomotor activity, catalepsy and recognition memory in these rats. Chronic risperidone treatment (0.2mg/kg) increased the extracellular levels of DA and 5-HT. Co-treatment with risperidone and escitalopram (5mg/kg) or mirtazapine (10mg/kg) more efficiently increased the release of 5-HT but not DA in the rat frontal cortex, as compared to drugs given alone. Moreover, risperidone, escitalopram and mirtazapine given alone or in combination significantly decreased the locomotor activity and only mirtazapine i...Continue Reading

References

Oct 15, 1984·European Journal of Pharmacology·J E Freedman, G K Aghajanian
Jun 3, 1996·European Journal of Pharmacology·K WedzonyK Gołembiowska
Jun 1, 1997·The American Journal of Psychiatry·M F GreenJ Mintz
Mar 17, 2000·Brain Research. Brain Research Reviews·G K Aghajanian, G J Marek
Apr 24, 2003·Psychopharmacology·Mary C Wolff, J David Leander
May 16, 2006·Behavioural Brain Research·Tim KarlIrina Dedova
Nov 1, 2007·The International Journal of Neuropsychopharmacology·Bob OranjeBirte Y Glenthøj
May 30, 2008·Pharmacology, Biochemistry, and Behavior·Alberto Del Arco, Francisco Mora
Sep 16, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jenny L Wiley, Rhys L Evans
Aug 9, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Caitlin E McOmishJay A Gingrich
Oct 19, 2016·Pharmacological Reports : PR·Katarzyna KamińskaKrystyna Gołembiowska
Apr 18, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Aung Aung Kywe MoeDarryl W Eyles

❮ Previous
Next ❯

Citations

Sep 6, 2020·Pharmacological Reports : PR·Przemysław J DanekWładysława A Daniel
Dec 19, 2020·International Journal of Molecular Sciences·Daniil Grinchii, Eliyahu Dremencov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here